1,721,009 research outputs found
Normative needs in healthcare: toward a new conceptualization of equity and capabilities.
No full textNORMATIVE NEEDS IN HEALTHCAR
Cost effectiveness studies in HIV treatment with Lopinavir/Ritonavir: a Review.
Full text linkCOST EFFECTIVENESS, HIV TREATMENT
Assessing the ethics of prison policies to ensure human rights compliance. Suicides and self-inflicted critical events in Italian prisons
Full text linkConsidering self-inflicted critical events (suicides, attempted suicides, self-harm acts, hunger strikes) in Italian prisons as indicators of the respect of inmates’ human rights, this study examines their relationship with the characteristics of the Italian prison system between 2016 and 2021, using a unique prison-level dataset covering the 188 national prisons. Both individual panel regressions and seemingly unrelated regressions show that reducing prison overcrowding reduces critical events. The same result is achieved by increasing mandatory treatments (restraint acts) performed discretionally by prison staff. Because the former policy is politically sensitive and difficult/costly to implement, policymakers may prefer to rely on the latter as a “death-avoidance strategy”, despite the greater likelihood of violating inmates’ human rights. These findings may help explain the increasing use of acts of restraint in Italian prisons in recent times
Economic assessment of an anti-HCV screening program in Italy
No full textThe progression of hepatitis C virus (HCV) disease usually occurs over a 10-year period. HCV-related complications as well as the highly debilitating effects on patients represent a significant item of expenditure for the National Health Service. Early detection of HCV infection is an excellent opportunity to improve patients' quality of life and to rationalize resource allocation
Economic evaluation of screening programs for HCV: evidence from literature.
No full textECONOMICS, SCREENING ANTI HC
Do Probability and Certainty Equivalent techniques lead to inconsistent results? Evidence from gambles involving life years and quality of life.
No full textSTASNDARD GAMBLE, QALY
Valutazione economica di Teysuno nel trattamento del Carcinoma gastrico avanzato
No full textwe aimed to investigate the cost effectiveness of s1-teysuno for the end of stage gastric carcinoma. results showed how s1 is cost effectiv
Healthcare Reform, Quality and Safety. Perspectives, Participants and Prospects in 30 countries
No full textThe book offers a global perspectives on healthcare reform and its relationship with efforts to improve quality and safet
Economic Assessment of an Anti-HCV Screening Program in Italy
No full textBackground: The progression of hepatitis C (HCV) is usually developed over
a ten-year-period. A high percentage of patients with chronic HCV contracts
cirrhosis. The probability of developing liver cancer from chronicHCV over a
year is 5%. These complications as well as the highly debilitating effects on
patients, represent a significant item of expenditure for the National Health
Service (NHS). Within the high risk population, the prevalence of the disease
is 9-10% and is characterized, in the Italian scenario, by a high North-South
gradient. Early detection of HCV is an excellent opportunity to improve
patients’ QOL and to rationalize resource allocation, since the disease is
characterized by a long preclinical phase, by the availability of treatments
that can improve the prognosis and, moreover, by a high prevalence in the
target population.
Objectives: The aim of this study is to provide a cost-effectiveness evaluation
of an anti-HCV screening program in the Italian NHS perspective
Healthcare expenditure on prevention in the spending review era
No full textDisease prevention is the most valuable tool to improve the control individuals have over their health. Nevertheless, OECD countries allocate on average 6% of health spending upon prevention activities. In Italy, in 2012, public expenditure on health care in the living and working environment was 0.34% of GDP; health spending devoted to the collective assistance in the same year constituted 4.1% of health spending (4.8 billion euros). At the interregional level, differences are marked: the effects of this heterogeneity are more acute in times of economic crisis, when the spread of unhealthy behaviours are associated more vigorously barriers to access to prevention programs. The objective of this work is to provide evidence on the cost-effectiveness of funded prevention programs in Italy, focusing on vaccination and screening programs, using this evidence to create a predictive tool for the evaluation of allocative efficiency related to the expenditure on prevention in Italy
- …
